Everest Biolabs Awarded $2.1 Million NIH SBIR Grant to Advance Extracellular Vesicle Biomarker Discovery at Scale with High-Purity, High-Throughput Isolation
Direct-to-Phase II award from the National Institute of General Medical Sciences will fund development of automated, plate-based, next-generation EV isolation technology for clinical-scale plasma biomarker studies WALTHAM, Mass., Sept. 24, 2026 /PRNewswire/ -- Everest Biolabs, a...
Covered in this story
What has happened since
- Everest Group is up 5.7% since this was published, 26 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Everest Group →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.